Please note: The Reglan information on our site is for reference only. Due to Statute of Limitations requirements, our firm no longer accepts Reglan drug claims for individuals injured as adults. However, some exceptions may apply to those injured by Reglan as minors.
Special Alert: July 2009
Studies have linked long-term use of the drug Reglan to the development of tardive dyskinesia (TD). A serious and potentially permanent neurological disorder, TD affects the central nervous system and leads to involuntary, repetitive movements of the face and extremities.
In February 2009, the Food and Drug Administration (FDA) announced a black box warning for Reglan, cautioning users of the drug's link to TD. There is currently no effective treatment for the disorder.
Reglan, generic name Metoclopramide, is a prescription drug used to treat gastrointestinal disorders like acid reflux disease and heartburn. The medication is available in the form of tablets, oral disintegrating tablets, oral solutions, and injections.
Recently published studies have found that Reglan (Metoclopramide) is the most common cause of drug-induced movement disorders. Additional FDA analysis of the studies showed that approximately 20 percent of patients who used Metoclopramide took it for longer than the recommended time period.
Reglan is approved for short-term use only, in periods of no longer than three months. However, many patients have been prescribed the medication for a year or more. In February 2009, the FDA mandated that manufacturers of Metoclopramide must add boxed warnings to their drug labels about the risk of the drug's long-term or high-dose use.
If you or a loved one has developed tardive dyskinesia after taking Reglan, you need to act quickly. When our drug injury attorneys and staff get involved with your case, we immediately get to work investigating the cause of your drug reaction and fighting for your legal rights to fair compensation.
Contact our law firm today by taking advantage of our free legal consultation.